We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Probe of GSK’s China Operations Targeting Chinese Executives
Probe of GSK’s China Operations Targeting Chinese Executives
November 11, 2013
Chinese authorities reportedly are preparing to prosecute individual GlaxoSmithKline officials in China for bribery, rather than bring charges against GSK’s entire China division, according to sources with knowledge of the ongoing investigation.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor